After this stage, the occurrence of additional mutations at the level of K-RAS, p53 and SMAD4, favor tumor promotion and progression, characterized by the increased growth rate of the adenoma, the expansion of individual particularly malignant clones, with consequent tumor invasion and metastasis (Figure 3). This evidence concerns the gene KRAS and neoplasm.